Atjaunināt sīkdatņu piekrišanu

Blocking Patents in European Competition Law: The Implications of the Concept of Abuse [Hardback]

  • Formāts: Hardback, 400 pages
  • Sērija : International Competition Law Series
  • Izdošanas datums: 03-Dec-2021
  • Izdevniecība: Kluwer Law International
  • ISBN-10: 9403538147
  • ISBN-13: 9789403538143
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 135,00 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 400 pages
  • Sērija : International Competition Law Series
  • Izdošanas datums: 03-Dec-2021
  • Izdevniecība: Kluwer Law International
  • ISBN-10: 9403538147
  • ISBN-13: 9789403538143
Citas grāmatas par šo tēmu:

In practice and jurisprudence in European competition law, it is especially difficult to define the boundaries of patent abuse as an offence. In this thoroughly researched book, the author answers the question of when and how an application for a blocking patent can amount to an abuse of a dominant position under Article 102 TFEU. Drawing on legal literature and European Union (EU) case law, the presentation analyses a constellation of blocking patenting strategies and proposes potential remedies where abuse is involved.

With detailed descriptions of the characteristics of potentially abusive and non-abusive behaviour regarding applications for blocking patents, the book provides the following and more:

  • a comprehensive analysis of the case law of the EU courts on the abuse of a dominant position in cases which involve intellectual property rights;
  • insights on how patenting strategies affect competition with a particular focus on the application of blocking patents;
  • an overview of the developments in doctrine and practice which led to the current understanding of the seemingly conflictual goals of competition and intellectual property law; and
  • insights on the difficulties of defining relevant markets and establishing whether an undertaking holds a dominant position.

The book illustrates the mechanisms of blocking patenting strategies with examples from the pharmaceutical industry because blocking strategies have particular relevance in applying for patents in that context. A test scheme for analysing the application of a blocking patent under Article 102 TFEU is included. Additionally, the book provides an outlook on the topic of patents and shortages of supply in light of the COVID pandemic.

Practitioners and policymakers requiring an understanding of the conceptual framework of the abuse concept within EU competition law and how it relates to patent strategies will welcome this invaluable book. They will not only be able to set the conduct of applying for blocking patents into the Article 102 TFEU context but also have decisive tools to approach questions on the intersection of patent law and competition law in the EU.
 

List of Abbreviations
xvii
Acknowledgements xxiii
Introduction Subject, Purpose and Method 1(2)
Chapter 1 Subject and Purpose
3(4)
I Subject
3(2)
II Purpose
5(2)
Chapter 2 Method
7(10)
I The Sources of EU Competition Law
7(1)
II Intersection Between Patent and Competition Law: Consequences for the Analysis
8(1)
III Approaching `Abuse'
8(3)
IV Reference to the Pharmaceutical Industry
11(1)
V Applicable and Comparative Law
12(1)
VI International Aspects
13(4)
Part I An Introduction to Competition
17(60)
Chapter 3 Competition: An Approximation
19(16)
I Introduction
19(1)
II The Economic Constitution of the European Union
20(2)
III Competition as an Object of Policymaking and Law
22(8)
1 Perfect Competition
23(1)
2 Workable and Effective Competition
24(1)
3 Free Competition
25(2)
4 The Chicago and Post-Chicago School
27(1)
5 Development of the More Economic Approach in the EU
28(2)
IV Welfare Standard
30(2)
V Implications
32(3)
Chapter 4 Introduction to the System of Competition Law
35(24)
I The Disciplines of Competition Law
35(6)
1 Antitrust Law/Competition Law in the Narrow Sense
35(1)
2 Law Against Unfair Competition
36(1)
2.1 Object
36(1)
2.2 Further Relevance of the Law Against Unfair Competition in This Book
37(2)
3 Intellectual Property Law
39(2)
II Patents in Competition
41(16)
1 Justification of Patent Law
41(1)
1.1 Classical Theories
42(1)
1.2 Modern Approach
43(1)
1.3 Critique of Patents
44(2)
2 The Relationship Between Patent and Competition Law
46(1)
2.1 Development of the Underlying Principles Based on the Example of the USA
46(1)
a Conflict Thesis
46(1)
b Compatibility (Harmony) Thesis
47(2)
c Complementary Thesis
49(1)
2.2 Development in the EU
50(1)
a Existence and Exercise
50(1)
b The Specific Subject Matter
51(2)
c The Modern Approach
53(2)
3 Restriction of Property Rights for the Goals of the Union
55(2)
III Implications
57(2)
Chapter 5 Introduction to Competition in the Pharmaceutical Market
59(18)
I Introduction
59(1)
II The Situation in the Market
60(4)
1 Supply Side
60(1)
2 Demand Side
61(1)
3 Products (Types of Drugs)
62(1)
3.1 New Medical Entities
62(1)
3.2 Me-too Drugs
63(1)
3.3 Second-Generation Products
63(1)
3.4 Generics
64(1)
III Drug Research
64(2)
1 Drug Research and Development
64(1)
1.1 Costs and Duration
64(1)
1.2 Pharmaceutical Product Life Cycle
65(1)
2 Systematics of Drug Development
66(4)
2.1 A Brief Historical Perspective
67(1)
2.2 Drug Discovery Today
67(1)
a Discovery Period (Basic Research)
68(1)
b Preclinical Trials
68(1)
c Clinical Trials
69(1)
d Marketing Approval and Monitoring
70(1)
IV The Importance of Patents for the Pharmaceutical Sector
70(6)
1 Types of Pharmaceutical Patents
71(1)
1.1 Product Patents
71(1)
1.2 Process Patents
72(1)
1.3 Use Patents
72(1)
2 Different Pharmaceutical Products
73(1)
2.1 Structurally Similar Active Substances
74(1)
a Isomers
74(1)
b Crystalline Forms
74(1)
c Derivates, such as Salts, Esters or Ethers
74(1)
2.2 Metabolites and Prodrugs
75(1)
2.3 Combinations of Ingredients
75(1)
3 Reference Points for Patenting Strategies
75(1)
V Implications
76(1)
Part II Strategic Patenting
77(32)
Chapter 6 Why Firms Patent
79(12)
I Patentability Requirements
79(2)
1 Inventions
80(1)
2 Novelty
80(1)
3 The Inventive Step and Non-obviousness
81(1)
4 Applicability
81(1)
II Motives to Patent
81(5)
1 Traditional Motives
82(1)
2 Strategic Motives
83(1)
2.1 Blocking Motive
83(2)
2.2 Other Strategic Motives
85(1)
III Blocking Patents
86(2)
1 The Phenomenon
86(1)
2 `Blocking Trademarks'
86(1)
3 Appearance
87(1)
IV Implications
88(3)
Chapter 7 Patenting Strategies
91(18)
I Development of Patenting Strategies
91(2)
II Offensive Versus Defensive Patenting
93(1)
III Patenting Strategies and Their Blocking Impact on Competition and Innovation
94(11)
1 Basic Patent
95(1)
1.1 Definition
95(1)
1.2 Blocking Potential of Basic Patents
95(2)
1.3 Effects of Blocking Basic Patents on the Market
97(2)
2 Fencing and Flooding
99(1)
2.1 Definition
99(3)
2.2 Effects of Blocking Patents on the Market in Fencing and Flooding Strategies
102(1)
a Different Patent Holders Holding Patents of a Patent Cluster
102(1)
b One Patent Holder Holds the Patent Cluster
103(1)
3 Evergreening
104(1)
4 Pre-empted Patent Application
105(1)
IV Patent Law Remedies to Counter Blocking Patents
105(2)
V Summary of the Preceding Evaluation
107(2)
Part III Defining Markets and Establishing Dominance
109(28)
Chapter 8 Market Power Versus Dominance: Introduction and Definition
111(4)
Chapter 9 Market Definition
115(14)
I The Relevant Market: A Definition
115(1)
II Patents and the Definition of the Relevant Market
116(1)
III Product Market
117(5)
1 General Considerations
117(1)
2 Quantitative Approaches
118(1)
3 Qualitative Approaches
119(1)
4 Pharmaceutical Product Markets
120(2)
IV Technology or Licensing Markets
122(3)
1 General Considerations
122(1)
2 Pharmaceutical Technology Markets
123(2)
V Innovation Market
125(4)
Chapter 10 Establishing a Dominant Position
129(6)
I General Considerations
129(1)
II Relevant Factors in Assessing Market Power
130(2)
III Market Power and Patents
132(3)
Chapter 11 Consequences for the Evaluation of Conduct Involving Patents
135(2)
Part IV Implications from Case Law and the Patent Misuse Doctrine for Blocking
Patent Applications under EU Competition Law
137(2)
Chapter 12 Case Law on the Abuse of a Dominant Position and Patents
139(30)
I Introduction
139(1)
II CICRA and Others v. Renault
139(1)
III Tetra Pak I
140(2)
IV Terra Pak II
142(1)
V Magill, IMS Health and Microsoft
143(2)
VI AstraZeneca v. Commission
145(8)
1 Facts of the Case
145(1)
2 Reasoning Concerning the Acquisition of the Supplementary Protection Certificate by Delivering Misleading Information
146(2)
3 Analysis of the Case
148(1)
3.1 Comment on the Concept of Abuse as Used in the AstraZeneca Case
149(1)
a Elements of Abuses
149(1)
b The Relevance of Showing Anticompetitive Effects
149(1)
c Is There a `Role' for Intent?
150(1)
3.2 Interim Conclusion on Cases Involving Patents Within the Abuse Concept Delivered by the Court
151(2)
VII Boehringer Ingelheim
153(1)
VIII Servier
154(11)
1 Facts of the Case
154(2)
2 Reasoning of the Commission Concerning the Acquisition of the Azad Technology
156(1)
3 Definition of the Relevant Market
157(3)
4 Comment
160(1)
4.1 Implications for the Primary Acquisition of Blocking Patents
160(2)
4.2 Implications for the Secondary Acquisition of Blocking Patents
162(3)
IX Conclusions Drawn from Case Law
165(4)
Chapter 13 Implications of the Patent Misuse Doctrine
169(4)
I Limitations of the Conclusions Drawn from Case Law
169(1)
II Patent Misuse Doctrine
170(3)
1 Definition and Scope of the Patent Misuse
170(1)
2 Limitations of the Patent Misuse Doctrine in Identifying Abusive Behaviour
170(1)
3 Implications for Further Analysis
171(2)
Part V The Concept of Abuse in EU Competition Law
173(70)
Chapter 14 Analysis of Article 102 TFEU
175(44)
I Drafting History of Article 102 TFEU
175(2)
II Text-Based Approximation
177(3)
1 The Search for an EU-Autonomous Characterisation of the Term `Abuse'
177(1)
2 Etymology and Linguistic Usage
178(2)
III The Role and Structure of Article 102 TFEU
180(5)
1 The Role of Article 102 TFEU Within EU (Competition) Law
180(2)
2 Systematics of Article 102 TFEU
182(1)
3 Exclusionary and Exploitative Abuses
183(2)
IV The Concept of Abuse in Article 102 TFEU
185(32)
1 Overview of the Section
185(1)
2 Court Practice over Time
185(1)
2.1 From the Beginning to Commercial Solvents
185(2)
2.2 United Brands: Refusal to Supply, Discriminatory and Unfair Prices
187(3)
2.3 Hoffmann-La Roche and Intel: Fidelity Rebates and Exclusive Dealing
190(1)
a Hoffmann-La Roche
190(1)
b Intel
191(2)
2.4 AKZO: Predatory Pricing
193(1)
2.5 Hilti and Microsoft: Tying and Bundling
193(2)
2.6 Deutsche Telecom and TeliaSonera Sverige: Margin Squeeze
195(1)
2.7 Findings
195(3)
3 `Competition on the Merits'
198(1)
3.1 Appearance of the Principle
198(2)
3.2 Relevance in Practice
200(2)
4 Form-Based Versus Effect-Based Concepts
202(1)
4.1 Anticompetitive Effects
202(1)
a The Difficulty of Measuring Anticompetitive Effects
202(1)
b The Elements of Market Structure
203(1)
c Changeability of Market Structure
204(2)
4.2 Intent
206(1)
a The Problem with Identifying Intent
206(3)
b Case Law on the Role of Intent in EU Competition Law
209(3)
c The Role of Intent in EU Competition Law: A Comment Based on Case Law
212(3)
5 Results
215(2)
V Conclusion
217(2)
Chapter 15 Abuse of a Dominant Position as a Manifestation of the Abuse of Rights?
219(24)
I Overview of the
Chapter
219(1)
II Similarities Between the Abuse of Rights and the Abuse of a Dominant Position
220(3)
1 Recapitulation of the Analysis
220(1)
1.1 Historical Perspective
220(1)
1.2 Textual Analysis
220(1)
1.3 The Role and Structure of Article 102 TFEU
221(1)
1.4 The Courts' Understanding of Abuse in Article 102 TFEU
221(1)
1.5 Results of the Interpretation
221(1)
2 Limiting `Power' to Prevent Failure
222(1)
III Abuse of Rights in EU Law
223(8)
1 Origins of the General Principle of the Abuse of Rights
223(2)
2 Development in Early French and German Law
225(1)
3 Adoption of a General Principle of Law at the Union Level
226(1)
3.1 Prerequisites for the Acknowledgement of a General Principle Within the Law of the Union
226(1)
3.2 The Common Denominator in the Member States
227(1)
3.3 Findings from Case Law
228(3)
IV Abuse of Rights Principle Within the Abuse of a Dominant Position
231(8)
1 Theoretical Foundation
231(2)
2 Limitations to the Freedom of Competition
233(3)
3 Findings from the Analysis of the Drafting History of Article 102 TFEU in Comparison with Section 2 Sherman Act
236(2)
4 Understandings from Italy's Pfizer Decision
238(1)
V Conclusion
239(4)
Part VI Blocking Patents as Abuse of a Dominant Position
243(62)
Chapter 16 Synthesis of the Preceding Analysis
245(4)
I Article 102 TFEU
245(1)
II Relationship Between Patents and Article 102 TFEU
246(1)
III Outline of Further Analysis
246(3)
Chapter 17 Distortion of Competition Through Patent Application
249(14)
I Outline of the
Chapter
249(1)
II The Influence of Patents on Innovation and Difficulties Regarding the Measurement of Innovation
250(1)
III The Effect of Patents on Competition and Innovation Within the Application Process
251(8)
1 Before the Publication of the Application
251(1)
2 After the Publication of the Application
252(3)
3 After the Grant of the Patent
255(1)
3.1 The Power of the Patent Holder
255(1)
3.2 Distorting Effect of Patents
256(1)
3.3 Patent Pools as a Remedy to Counteract the Deterrent Effect of the Presence of Patents?
257(1)
3.4 Patent Invalidation
258(1)
IV Conclusion
259(4)
Chapter 18 Balancing Interests
263(42)
I The Relevance of Fundamental Rights for the Analysis
263(3)
II Limitations to the Fundamental Right to Property
266(15)
1 Outline of the Section
266(1)
2 Patentability Requirements
267(1)
2.1 General Considerations
267(1)
2.2 Limitations to Patentability
268(3)
2.3 Comment
271(2)
2.4 Implications
273(1)
3 The Right to Not Use the Patent
273(1)
3.1 General Considerations
273(1)
3.2 Implications from the TRIPS Agreement
274(3)
3.3 Implications from Trademark Law
277(1)
3.4 Is Bad Faith Relevant in Patent Law after All?
278(2)
4 Conclusion
280(1)
III Unused Patents and the Purpose of Patent Law
281(10)
1 The Goal of This Section
281(1)
2 The Purpose of Patent Law
281(2)
3 Usage Requirement Analogous to Trademark Law
283(2)
4 The Interests of Securing One's Own Innovation
285(2)
5 The Effect of Weak Patents on the Market
287(2)
6 Implications
289(2)
IV Conclusion
291(2)
Findings
293(4)
Outlook: Global Shortages and the Role of Patents
297(1)
I Patents and Their Barriers
297(1)
II Are Patents Responsible for the Shortage?
298(2)
III Compulsory Licences as Internal Limitations to Patents
300(2)
IV Learnings
302(3)
Bibliography 305(28)
Table of Decisions 333(16)
Materials 349(6)
Index 355